RSNA 2008 CT Scanning

Radiation dose awareness leads to more pediatric referrals for ultrasound and MRI
December 7, 2008

Educational efforts to raise awareness about the associated risks of CT-based radiation exposure and the need to keep children from receiving unnecessary scans seem to be achieving traction among healthcare providers, according to a study by Ohio researchers. Their findings suggest that such increased awareness may make referring physicians less likely to order imaging that involves ionizing radiation for young patients.

GE introduces new PET/CT
December 5, 2008

Discovery PET/CT 600 debuted at the RSNA meeting, taking a midtier position in GE Healthcare’s family of hybrid devices.

Researchers find CT use not the cause of a rise in costs of hospital stay
December 4, 2008

Increased use of CT for pneumonia is unlikely to be the sole cause of increased hospital costs at Brigham and Women’s Hospital, according to a study presented Dec. 5 at RSNA

Philips unveils new 16-slice CT
December 4, 2008

A low-cost 16-slice scanner designed for cost-constrained customers debuted at the Philips booth during the RSNA meeting.

McFarland plots course toward acceptance of CT colonography
December 4, 2008

In the aftermath of Medicare’s less than encouraging evaluation of virtual CT colonography for colorectal cancer screening, Dr. Elizabeth McFarland used the RSNA’s Annual Oration in Diagnostic Radiology to identify past achievements and ongoing initiatives she believes will lead to the modality’s acceptance.

Researchers find low-dose PET/CT best imaging method for lymphoma
December 4, 2008

Low-dose PET/CT demonstrates the best sensitivity and specificity for initial staging of lymphoma, according to a study presented on Thursday at the RSNA meeting.

Studies attest to prognostic value of coronary CTA
December 3, 2008

In response to demands for evidence that cardiac CT will positively affect patient outcomes, researchers presented results at the RSNA conference Wednesday attesting to its value for identifying which intermediate risk patients are most likely to suffer future catastrophic coronary events.